Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Srikanth Yandrapalli, Aaqib Malik, Kenneth Guber, Yogitha Rochlani, Gayatri Pemmasani, Manasa Jasti & Wilbert S Aronow. (2019) Statins and the potential for higher diabetes mellitus risk. Expert Review of Clinical Pharmacology 12:9, pages 825-830.
Read now
Read now
Agostino Consoli, Gloria Formoso, Maria Pompea Antonia Baldassarre & Fabrizio Febo. (2018) A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment. Expert Opinion on Drug Safety 17:3, pages 293-302.
Read now
Read now
Articles from other publishers (33)
Seyyed Mojtaba Ghorashi, Mojtaba Salarifar, Hamidreza Poorhosseini, Saead Sadeghian, Arash Jalali, Hassan Aghajani, Ali-Mohammad Haji-Zeinali & Negar Omidi. (2022) Predictors of in-hospital mortality in diabetic patients with non-ST-elevation myocardial infarction. The Egyptian Heart Journal 74:1.
Crossref
Crossref
Shunichiro Tsukamoto, Ryutaro Morita, Takayuki Yamada, Shingo Urate, Kengo Azushima, Kazushi Uneda, Ryu Kobayashi, Tomohiko Kanaoka, Hiromichi Wakui & Kouichi Tamura. (2022) Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis. Diabetes Research and Clinical Practice 194, pages 110161.
Crossref
Crossref
Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang & Jinxi Zhao. (2022) Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease. Cardiovascular Diabetology 21:1.
Crossref
Crossref
Elizabeth K. PoggeNicole K. Early. (2022) Part Six: Antidiabetic Medication Benefits Beyond Glucose Lowering in Older People. The Senior Care Pharmacist 37:10, pages 477-487.
Crossref
Crossref
Paramesha Bugga, Soheb Anwar Mohammed, Md Jahangir Alam, Parmeshwar Katare, Himanshu Meghwani, Subir Kumar Maulik, Sudheer Arava & Sanjay Kumar Banerjee. (2022) Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress. Life Sciences 307, pages 120862.
Crossref
Crossref
Karine Suissa, Sebastian Schneeweiss, Antonios Douros, Hui Yin, Elisabetta Patorno & Laurent Azoulay. (2022) Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes. Diabetes Research and Clinical Practice 192, pages 110094.
Crossref
Crossref
Willemien J. Kruik-Kollöffel, Enriqueta Vallejo-Yagüe, Kris L. L. Movig, Gerard C. M. Linssen, Edith M. Heintjes & Job van der Palen. (2022) Non-cardiovascular medication and readmission for heart failure: an observational cohort study. International Journal of Clinical Pharmacy 44:3, pages 762-768.
Crossref
Crossref
Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, Nitin Chopra, Hirotaka Miyashita, Takahisa Mikami, Hiroki Ueyama, Tomohiro Fujisaki, Yusuke Saigusa, Takahiro Yamaji, Kengo Azushima, Shingo Urate, Toru Suzuki, Eriko Abe, Hiromichi Wakui & Kouichi Tamura. (2021) Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis. Cardiovascular Diabetology 20:1.
Crossref
Crossref
Kenneth Guber, Gayatri Pemmasani, Aaqib Malik, Wilbert S. Aronow, Srikanth Yandrapalli & William H. Frishman. (2020) Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications. Cardiology in Review 29:6, pages 314-322.
Crossref
Crossref
Suksamran Chaidam, Natthiya Saehlim, Anan Athipornchai, Uthaiwan Sirion & Rungnapha Saeeng. (2021) Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes. Bioorganic & Medicinal Chemistry Letters 50, pages 128331.
Crossref
Crossref
Jinyuan Zhang, Jian Xu, Jongcheon Lim, James K. Nolan, Hyowon Lee & Chi Hwan Lee. (2021) Wearable Glucose Monitoring and Implantable Drug Delivery Systems for Diabetes Management. Advanced Healthcare Materials 10:17, pages 2100194.
Crossref
Crossref
HoJin Shin, Sebastian Schneeweiss, Robert J. Glynn & Elisabetta Patorno. (2021) Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA. Diabetes Care 44:8, pages 1774-1782.
Crossref
Crossref
Rui Pan, Jian Lou & Ling Wei. (2021)
Significant effects of
Ganoderma lucidum
polysaccharide on lipid metabolism in diabetes may be associated with the activation of the FAM3C‑HSF1‑CAM signaling pathway
. Experimental and Therapeutic Medicine 22:2.
Crossref
Crossref
Bugga Paramesha, Mohammed Soheb Anwar, Himanshu Meghwani, Subir Kumar Maulik, Sudheer Kumar Arava & Sanjay K Banerjee. (2021) Sirt1 and Sirt3 Activation Improved Cardiac Function of Diabetic Rats via Modulation of Mitochondrial Function. Antioxidants 10:3, pages 338.
Crossref
Crossref
Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Alfredo Caturano, Erica Vetrano, Concetta Aprea, Gaetana Albanese, Anna Di Martino, Carmen Ricozzi, Simona Imbriani & Ferdinando Carlo Sasso. (2020) Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?. Biomedicines 9:1, pages 3.
Crossref
Crossref
Liliana Espinoza & Carie R Boychuk. (2020) Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions. Current Opinion in Pharmacology 54, pages 18-26.
Crossref
Crossref
Srikanth Yandrapalli, Aaqib Malik, Adam Horblitt, Gayatri Pemmasani, Wilbert S. Aronow & William H. Frishman. (2020) Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2. Cardiology in Review 28:5, pages 219-235.
Crossref
Crossref
Xinzhe Gu, Ying Yang & Zhengwu Wang. (2020) Nutritional, phytochemical, antioxidant, α-glucosidase and α-amylase inhibitory properties of Moringa oleifera seeds. South African Journal of Botany 133, pages 151-160.
Crossref
Crossref
Chris R. TriggleHong DingIsra MareiTodd J. AndersonMorley D. Hollenberg. (2020) Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease. Canadian Journal of Physiology and Pharmacology 98:7, pages 415-430.
Crossref
Crossref
Aaqib H. Malik, Srikanth Yandrapalli, Michael GoldbergDiwakar Jain, William H. Frishman & Wilbert S. Aronow. (2020) Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease. Cardiology in Review 28:3, pages 116-124.
Crossref
Crossref
Héctor Eloy Tamez-Pérez, Enrique Delgadillo-Esteban & Alejandra Lorena Tamez-Peña. (2020) Underutilization of insulin and better metabolic control. A NOVA clinic experience. Revista da Associação Médica Brasileira 66:3, pages 334-337.
Crossref
Crossref
Xue Jiang, Weiqi Meng, Lanzhou Li, Zhaoli Meng & Di Wang. (2020) Adjuvant Therapy With Mushroom Polysaccharides for Diabetic Complications. Frontiers in Pharmacology 11.
Crossref
Crossref
Hongzhong Ma, Juan Du, Xiaoli Feng, Yingjun Zhang, Haihuan Wang, Suchun Ding, Aijie Huang & Jiahai Ma. (2020) Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF‑κB signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Gaurav Gupta, Ridhima Wadhwa, Parijat Pandey, Sachin Kumar Singh, Monica Gulati, Saurabh Sajita, Meenu Mehta, Avinash Kumar Singh, Harish Dureja, Trudi Collet, Kavita Pabreja, Dinesh Kumar Chellappan & Kamal Dua. 2020. Pathophysiology of Obesity-Induced Health Complications. Pathophysiology of Obesity-Induced Health Complications
81
97
.
Samuel Ogheneovo Asagba, Helen Ejiro Kadiri & Theresa Ezedom. (2019) Biochemical changes in diabetic rats treated with ethanolic extract of Chysophyllum albidum fruit-skin. The Journal of Basic and Applied Zoology 80:1.
Crossref
Crossref
Willian Abraham da Silveira, Esteban Vazquez-Hidalgo, Elesha Bartolotta, Ludivine Renaud, Paul Paolini & Gary Hardiman. (2019) The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysis. Pharmacogenomics 20:16, pages 1125-1141.
Crossref
Crossref
Hong Ding, Kevin Ye & Chris R Triggle. (2019) Impact of currently used anti-diabetic drugs on myoendothelial communication. Current Opinion in Pharmacology 45, pages 1-7.
Crossref
Crossref
Patricia Keresztes & Annette Peacock-Johnson. (2019) CE: Type 2 Diabetes: A Pharmacologic Update. AJN, American Journal of Nursing 119:3, pages 32-40.
Crossref
Crossref
Srikanth Yandrapalli, Christopher Nabors, Abhishek Goyal, Wilbert S. Aronow & William H. Frishman. (2019) Modifiable Risk Factors in Young Adults With First Myocardial Infarction. Journal of the American College of Cardiology 73:5, pages 573-584.
Crossref
Crossref
Hadier M. El-sheikh, Sahar M. El-Haggar & Tamer A. Elbedewy. (2019) Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:1, pages 167-173.
Crossref
Crossref
A.J. Scheen. (2018) Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies. Diabetes & Metabolism 44:5, pages 386-392.
Crossref
Crossref
Selvaraj Kunjiappan, Theivendren Panneerselvam, Parvathy Prasad, Sunija Sukumaran, Balasubramanian Somasundaram, Murugesan Sankaranarayanan, Indhumathy Murugan & Pavadai Parasuraman. (2018)
Design, graph theoretical analysis and
in silico
modeling of
Dunaliella bardawil
biomass encapsulated keratin nanoparticles: a scaffold for effective glucose utilization
. Biomedical Materials 13:4, pages 045012.
Crossref
Crossref
Natalia V. Fedorova, Alexander L. Ksenofontov, Marina V. Serebryakova, Vladimir I. Stadnichuk, Tatjana V. Gaponova, Ludmila A. Baratova, Galina F. Sud’ina & Svetlana I. Galkina. (2018) Neutrophils Release Metalloproteinases during Adhesion in the Presence of Insulin, but Cathepsin G in the Presence of Glucagon. Mediators of Inflammation 2018, pages 1-9.
Crossref
Crossref